Navigation Links
Multiple Chemical Sensitivities Are Real
Date:5/7/2010

SWANTON, Vt., May 7 /PRNewswire/ -- This May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury Associations worldwide in their effort to spread Multiple Chemical Sensitivity Syndrome awareness.  

AllerAir will make chemical awareness tips and a $50.00 gift certificate available via their website at www.allerair.com.  Additionally, their blogs and articles will be dedicated to Multiple Chemical Sensitivities and chemical awareness topics for the month of May.  

Multiple Chemical Sensitivities affect over 48 million Americans.  The onset of this debilitating medical condition can cause an allergy-like reaction to even low levels of chemical exposure.  Often referred to as Toxic Injury or Chemical Sensitivity Syndrome, the onset of Multiple Chemical Sensitivities depends on either a single highly toxic chemical encounter, or repeated low-level chemical exposures.

Multiple Chemical Sensitivity Syndrome hits close to home for AllerAir president, Sam Teitelbaum.  He discovered the reality of chemical injury when a close relative was diagnosed with Multiple Chemical Sensitivities in 1990.  Since then, Sam has made it his mission to provide the chemically sensitive with the most inert air purifiers available.

According to Sam, "There are millions of people suffering today because of chemical injury and poor Indoor Air Quality (IAQ).  At AllerAir, we are committed to air quality education and chemical injury prevention and relief.  Millions of people have been affected by multiple chemical sensitivities, but the proliferation of airborne chemicals means that millions more will suffer unless we take stock of our indoor air quality."  

A Cornell study in 2007 revealed that over 3 million tons of toxins and hazardous chemicals are released into the air annually.  This does not include the pesticides used indoors, nor the hundreds of carcinogens found in cleaning products, fragrances and cosmetics.  This May, learn more about Multiple Chemical Sensitivity Syndrome, and how to protect your family.  

AllerAir Since 1996

AllerAir's smart design solutions provide the most effective balance of performance, safety, quality and price.  AllerAir air purifiers are equipped with many pounds of activated carbon, which is proven to be the most efficient way to treat toxic chemicals and gases.  AllerAir's Multiple Chemical Sensitivity air purifiers are built with the most inert products, and clients are able to test and select their own carbon with the carbon test kit.  Chemical exposure is linked to organ and central immune system damage, respiratory disorders and cancer.


'/>"/>
SOURCE AllerAir
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
2. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
3. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
4. Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes
5. iPhone Application Designed for Multiple Sclerosis Patients is Launched
6. New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use
7. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
8. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
9. Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
10. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
11. Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ... Quarter 2016 investor conference call and webcast at 8:30 a.m., ... call will cover an update on Merrimack,s recent progress as ... 2016 financial results. A press release detailing the information to ... of Wednesday, March 1. Investors and the general public are ...
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... heart failure partnering deals and agreements entered into ... the full report: http://www.reportlinker.com/p03605673-summary/view-report.html Description ... report provides understanding and access to partnering deals ... healthcare companies. - Trends in partnering ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
(Date:2/22/2017)... N.J. (PRWEB) , ... February 22, 2017 , ... ... a one-size-fits-all approach, leads to fewer trips the emergency room, fewer hospital admissions, ... The American Journal of Managed Care® (AJMC®) finds. The study can be found ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Doctors on Liens ... of esteemed ophthalmologist, Dr. Steven H. Rauchman, practicing at North Valley Eye Medical ... accidents, product liability, premise liability and other personal injury cases. These injuries have ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... country today, as organizations, advocates, and individuals join together to increase recognition about ... to ultimately save lives. , “Today we mark a nationwide movement to raise ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... of ProGen™ PRP, the latest innovation in the delivery of Platelet Rich Plasma ... aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and provide a faster ...
Breaking Medicine News(10 mins):